A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes

Nature Biotechnology

Volumn 16, Issue 13, 1998, Pages 1361-1364

  Zeitlin, Larry ^a   Olmsted, Stuart S ^b   Moench, Thomas R ^a   Co, Man Sung ^d   Martinell, Brian J ^c   Paradkar, Vikram M ^c   Russell, David R ^c   Queen, Cary ^d   Cone, Richard A ^a,b   Whaley, Kevin J ^a,b  

^a REPROTECT INC   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MONSANTO COMPANY   (United States)

^d PROTEIN DESIGN LABS INC   (United States)

Author keywords

Agricultural biotechnology; Applied immunology; Immunization

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; BIOTECHNOLOGY; CELL CULTURE; DRUG EFFICACY; DRUG SAFETY; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; IMMUNITY; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; TRANSGENIC PLANT; VAGINA DISEASE;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNITY, MUCOSAL; MICE; PLANTS, GENETICALLY MODIFIED; VAGINA;

GLYCINE MAX; HERPES; HUMAN HERPESVIRUS 2; MAMMALIA;

EID: 0031790556     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/4344     Document Type: Article

References (47)

1. Eng, T. and Butler, W. 1997. The hidden epidemic. National Academy Press, Washington, D.C.
2. Cone, R.A. and Whaley, K.J. 1994. Monoclonal antibodies for reproductive health: part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies. Am. J. Reprod. Immunol. 32:114-131.
3. Davidson, G.P., Whyte, P.B., Daniels, E., Franklin, K., Nunan, H., McCloud, P.I. et al. 1989. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 2:709-712.
4. Tamura, S., Funato, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. et al. 1991. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur. J. Immunol. 21:1337-1344.
5. Whaley, K.J., Zeitlin, L., Barratt, R.A., Hoen, T.E., and Cone, R.A. 1994. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J. Infect. Dis. 169:647-649.
6. Zeitlin, L., Whaley, K.J., Sanna, P.P., Moench, T.R., Bastidas, R., De Logu, A. et al 1996. Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2. Virology 225:213-215.
7. Zeitlin, L., Doctoral dissertation, Topical methods for preventing genital herpes infection in the mouse. The Johns Hopkins University, Baltimore, MD, 1996.
8. Co, M.S. and Queen, C. 1991. Humanized antibodies for therapy. Nature 351:501-502.
9. Burton, D. and Barbas, C. 1994. Human antibodies from combinatorial libraries. Adv. Immunol. 57:191-280.
10. Winter, G., Griffiths, A., Hawkins, R., and Hoogenboom, H. 1994. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:433-455.
11. Williamson, R., Burioni, R., Sanna, P., Partridge, L., Barbas, C., and Burton, D. 1993. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. Proc. Natl. Acad. Sci. USA 90:4141-4145.
12. Hiatt, A., Caffertey, R., and Bowdish, K. 1989. Production of antibodies in transgenic plants. Nature 342:76-78.
13. Ma, J., Hiatt, A., Hein, M., Vine, N., Wang, F., Stabila, P. et al. 1995. Generation and assembly of secretory antibodies in plants. Science 268:716-719.
14. Hiatt, A. 1990. Antibodies produced in plants. Nature 344:469-470.
15. Wright, A. and Morrison, S. 1997. Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol. 15:26-32.
16. Co, M.S., Deschamps, M., Whitley, R.J., and Queen, C. 1991. Humanized antibodies for antiviral therapy. Proc. Natl. Acad. Sci. USA 88:2869-2873.
17. Fleming, D., McQuillian, G., Johnson, R., Nahmias, A., Aral, S., Lee, F. et al. 1997. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 337:1105-1111.
18. Hook, E.W., Cannon, R.O., Nahmias, A.J., Lee, F.F., Campbell, C.H., Glasser, D. et al. 1992. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J. Infect. Dis. 165:251-255.
19. Gwanzura, L., McFarland, W., Alexander, D., Burke, R.L., and Katzenstein, D. 1998. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J. Infect. Dis. 177:481-484.
20. Saltzman, W.M., Radomsky, M.L., Whaley, K.J., and Cone, R.A. 1994. Antibody diffusion in human cervical mucus. Biophys. J. 66:508-515.
21. Cone, R. 1999. Mucus, pp. 43-64 in Handbook of mucosal immunology, 2nd ed. Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., McGhee, J.R., Bienenstock, J. (eds.). Academic Press, Washington, D.C. In press.
22. Whaley, K.J., Barratt, R.A., Zeitlin, L., Hoen, T.E., and Cone, R.A. 1993. Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections. J. Infect. Dis. 168:1009-1011.
23. Cai, W., Gu, B., and Person, S. 1988. Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J. Virol. 62:2596-2604.
24. Hiatt, A. and Ma, J.-C. 1992. Monoclonal antibody engineering in plants. FEBS Lett. 307:71-75.
25. Fiedler, U. and Conrad, U. 1995. High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Bio/Technology 13:1090-1093.
26. Hiatt, A. and Ma, J.-C. 1993. Characterization and applications of antibodies produced in plants. Int. Rev. Immunol. 10:139-152.
27. Friberg, J. 1974. Sperm-agglutinating antibodies and immunoglobulins G and A in stored human seminal fluid. Acta Obstet. Gyn. Scand. Suppl. 36:59-63.
28. Tjokronegoro, A. and Sirisinha, S. 1974. Degradation of immunoglobulins by secretions of human reproductive tracts. J. Reprod. Fertil. 38:221-224.
29. Castle, P. 1995. Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbit. (Doctoral dissertation). Johns Hopkins University, Baltimore, MD.
30. Zeitlin, L., Whaley, K.J., Hegarty, T., Moench, T.R., and Cone, R.A. 1997. Tests of vaginal microbicides in the mouse genital herpes model. Contraception 56:329-335.
31. Elias, C. and Heise, L. 1994. Challenges for the development of female-controlled vaginal microbicides. AIDS 8:1-9.
32. Stone, A. and Hitchcock, P. 1994. Vaginal microbicides for preventing the sexual transmission of AIDS. AIDS (suppl 1) 8:S285-S293.
33. Stein, Z. 1990. HIV prevention: the need for methods women can use. Am. J. Public Health 80:460-462.
34. Sherwood, J.K., Zeitlin, L., Chen, X., Whaley, K.J., Cone, R.A., and Saltzman, W.M. 1996. Residence half-life of IgG administered topically to the mouse vagina. Biol. Reprod. 54:264-269.
35. Sherwood, J.K., Zeitlin, L., Whaley, K.J., Cone, R.A., and Saltzman, W.M. 1996. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Nat. Biotechnol. 14:468-471.
36. Radomsky, M.L., Whaley, K.J., Cone, R.A., and Saltzman, W.M. 1992. Controlled vaginal delivery of antibodies in the mouse. Biol. Reprod. 47:133-140.
37. Ma, J.K. and Hein, M.B. 1995. Immunotherapeutic potential of antibodies produced in plants. Trends Biotechnol. 13:522-527.
38. Miele, L. 1997. Plants as bioreactors for biopharmaceuticals: regulatory considerations. Trends Biotechnol. 15:45-50.
39. Ma, J. K-C., Hikmat, B.Y., Wycoff, K., Vine, N.D., Chargelegue, D., Yu, L. et al. 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. 4:601-606.
40. Sherman-Gold, R. August 1997. Monoclonal antibodies: the evolution from '80s magic bullets to mature, mainstream applications as clinical therapeutics. Genetic Engineering News. August, p. 4.
41. Wong, J. 1998. Monoclonals to hit stride in '98. Genetic Engineering News. January, p. 21.
42. Zeitlin, L., Cone, R.A., and Whaley, K.J. Monoclonal antibodies for preventing mucosal transmission of epidemic infectious diseases. Emerg. Infect. Dis. In press.
43. Francisco, J.A., Gawlak, S.A., Miller, M., Bathe, J., Russell, D., Chance, D. et al. 1997. Expression and characterization of bryodin 1 and a bryodin 1-based single-chain immunotoxin from tobacco cell culture. Bioconjugate Chem. 8:708-713.
44. McCabe, D.E., Swain, W.F., Martinell, B.J., and Christou, P. 1988. Stable transformation of soybean (Glycine max) by particle acceleration. Bio/Technology 6:923-926.
45. Wolf, D. 1989. Designing, building, and using a fluorescence recovery after photobleaching instrument. pp 271-306 in Fluorescence microscopy of living cells in culture. Part B. Taylor, D. and Wang, Y. (eds.). Academic Press, San Diego, CA.
46. Barisas, B. and Leuther, M. 1977. Fluorescence photobleaching recovery measurement of protein absolute diffusion constants. Biophys. Chem. 10:221-229.
47. Matthews, D. and Farewell, V. 1985. Using and understanding medical statistics. Karger, Basel, Switzerland.